331 related articles for article (PubMed ID: 10448061)
1. Resveratrol is a selective human cytochrome P450 1A1 inhibitor.
Chun YJ; Kim MY; Guengerich FP
Biochem Biophys Res Commun; 1999 Aug; 262(1):20-4. PubMed ID: 10448061
[TBL] [Abstract][Full Text] [Related]
2. Mechanism-based inhibition of human cytochrome P450 1A1 by rhapontigenin.
Chun YJ; Ryu SY; Jeong TC; Kim MY
Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):389-93. PubMed ID: 11259321
[TBL] [Abstract][Full Text] [Related]
3. Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2.
Chang TK; Chen J; Lee WB
J Pharmacol Exp Ther; 2001 Dec; 299(3):874-82. PubMed ID: 11714871
[TBL] [Abstract][Full Text] [Related]
4. The inhibitory effect of tannic acid on cytochrome P450 enzymes and NADPH-CYP reductase in rat and human liver microsomes.
Yao HT; Chang YW; Lan SJ; Yeh TK
Food Chem Toxicol; 2008 Feb; 46(2):645-53. PubMed ID: 17950511
[TBL] [Abstract][Full Text] [Related]
5. A new selective and potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis.
Chun YJ; Kim S; Kim D; Lee SK; Guengerich FP
Cancer Res; 2001 Nov; 61(22):8164-70. PubMed ID: 11719446
[TBL] [Abstract][Full Text] [Related]
6. Potent inhibition of recombinant human cytochrome p-450 1A1 by pentamethoxystilbene.
Lee SK; Kim Y; Kim MY; Chun YJ; Kim S
J Toxicol Environ Health A; 2004 Dec; 67(23-24):1987-2000. PubMed ID: 15513897
[TBL] [Abstract][Full Text] [Related]
7. The alkaloid rutaecarpine is a selective inhibitor of cytochrome P450 1A in mouse and human liver microsomes.
Ueng YF; Jan WC; Lin LC; Chen TL; Guengerich FP; Chen CF
Drug Metab Dispos; 2002 Mar; 30(3):349-53. PubMed ID: 11854157
[TBL] [Abstract][Full Text] [Related]
8. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
[TBL] [Abstract][Full Text] [Related]
9. Involvement of cytochrome P450 1A in sanguinarine detoxication.
Vrba J; Kosina P; Ulrichová J; Modrianský M
Toxicol Lett; 2004 Jul; 151(2):375-87. PubMed ID: 15183462
[TBL] [Abstract][Full Text] [Related]
10. Kinetics and selectivity of mechanism-based inhibition of guinea pig hepatic and pulmonary cytochrome P450 by N-benzyl-1-aminobenzotriazole and N-alpha-methylbenzyl-1-aminobenzotriazole.
Sinal CJ; Bend JR
Drug Metab Dispos; 1996 Sep; 24(9):996-1001. PubMed ID: 8886610
[TBL] [Abstract][Full Text] [Related]
11. Diterpene quinone tanshinone IIA selectively inhibits mouse and human cytochrome p4501A2.
Ueng YF; Kuo YH; Peng HC; Chen TL; Jan WC; Peter Guengerich F; Lin YL
Xenobiotica; 2003 Jun; 33(6):603-13. PubMed ID: 12851037
[TBL] [Abstract][Full Text] [Related]
12. The presence of inducible cytochrome P450 types 1A1 and 1A2 in the BeWo cell line.
Avery ML; Meek CE; Audus KL
Placenta; 2003 Jan; 24(1):45-52. PubMed ID: 12495659
[TBL] [Abstract][Full Text] [Related]
13. In vitro inhibitory effect of luotonin A on human CYP1A.
Jahng Y; Kwon OK; Lee S
Arch Pharm Res; 2012 Dec; 35(12):2199-203. PubMed ID: 23263815
[TBL] [Abstract][Full Text] [Related]
14. Interactions among P450 enzymes when combined in reconstituted systems: formation of a 2B4-1A2 complex with a high affinity for NADPH-cytochrome P450 reductase.
Backes WL; Batie CJ; Cawley GF
Biochemistry; 1998 Sep; 37(37):12852-9. PubMed ID: 9737863
[TBL] [Abstract][Full Text] [Related]
15. Effect of sulfur dioxide inhalation on CYP1A1 and CYP1A2 in rat liver and lung.
Qin G; Meng Z
Toxicol Lett; 2005 Dec; 160(1):34-42. PubMed ID: 16023800
[TBL] [Abstract][Full Text] [Related]
16. Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes.
Yamazaki H; Nakano M; Gillam EM; Bell LC; Guengerich FP; Shimada T
Biochem Pharmacol; 1996 Jul; 52(2):301-9. PubMed ID: 8694855
[TBL] [Abstract][Full Text] [Related]
17. Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies.
Kranendonk M; Carreira F; Theisen P; Laires A; Fisher CW; Rueff J; Estabrook RW; Vermeulen NP
Mutat Res; 1999 Apr; 441(1):73-83. PubMed ID: 10224324
[TBL] [Abstract][Full Text] [Related]
18. Microsomal cytochrome P450 1A1 dependent monooxygenase activity in guinea pig heart: induction, inhibition, and increased activity by addition of exogenous NADPH-cytochrome P450 reductase.
McCallum GP; Horton JE; Falkner KC; Bend JR
Can J Physiol Pharmacol; 1993 Feb; 71(2):151-6. PubMed ID: 8319138
[TBL] [Abstract][Full Text] [Related]
19. 3-aminobenzanthrone, a human metabolite of the environmental pollutant 3-nitrobenzanthrone, forms DNA adducts after metabolic activation by human and rat liver microsomes: evidence for activation by cytochrome P450 1A1 and P450 1A2.
Arlt VM; Hewer A; Sorg BL; Schmeiser HH; Phillips DH; Stiborova M
Chem Res Toxicol; 2004 Aug; 17(8):1092-101. PubMed ID: 15310241
[TBL] [Abstract][Full Text] [Related]
20. Activation of microsomal glutathione S-transferase and inhibition of cytochrome P450 1A1 activity as a model system for detecting protein alkylation by thiourea-containing compounds in rat liver microsomes.
Onderwater RC; Commandeur JN; Menge WM; Vermeulen NP
Chem Res Toxicol; 1999 May; 12(5):396-402. PubMed ID: 10328749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]